vs
CORCEPT THERAPEUTICS INC（CORT）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
CORCEPT THERAPEUTICS INC的季度营收约是ROGERS CORP的1.0倍（$202.1M vs $200.5M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs 2.2%，领先9.8%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 5.2%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $1.1M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs -3.3%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
CORT vs ROG — 直观对比
营收规模更大
CORT
是对方的1.0倍
$200.5M
营收增速更快
CORT
高出5.9%
5.2%
净利率更高
CORT
高出9.8%
2.2%
自由现金流更多
CORT
多$37.3M
$1.1M
两年增速更快
CORT
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $200.5M |
| 净利润 | $24.3M | $4.5M |
| 毛利率 | 98.7% | 32.2% |
| 营业利润率 | 2.2% | — |
| 净利率 | 12.0% | 2.2% |
| 营收同比 | 11.1% | 5.2% |
| 净利润同比 | -21.0% | 421.4% |
| 每股收益（稀释后） | $0.20 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $202.1M | $201.5M | ||
| Q3 25 | $207.6M | $216.0M | ||
| Q2 25 | $194.4M | $202.8M | ||
| Q1 25 | $157.2M | $190.5M | ||
| Q4 24 | $181.9M | $192.2M | ||
| Q3 24 | $182.5M | $210.3M | ||
| Q2 24 | $163.8M | $214.2M |
净利润CORTROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $24.3M | $4.6M | ||
| Q3 25 | $19.7M | $8.6M | ||
| Q2 25 | $35.1M | $-73.6M | ||
| Q1 25 | $20.5M | $-1.4M | ||
| Q4 24 | $30.7M | $-500.0K | ||
| Q3 24 | $47.2M | $10.7M | ||
| Q2 24 | $35.5M | $8.1M |
毛利率CORTROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 98.7% | 31.5% | ||
| Q3 25 | 97.8% | 33.5% | ||
| Q2 25 | 98.2% | 31.6% | ||
| Q1 25 | 98.5% | 29.9% | ||
| Q4 24 | 98.4% | 32.1% | ||
| Q3 24 | 98.4% | 35.2% | ||
| Q2 24 | 98.5% | 34.1% |
营业利润率CORTROG
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 3.5% | ||
| Q3 25 | 4.9% | 7.3% | ||
| Q2 25 | 13.7% | -33.3% | ||
| Q1 25 | 2.2% | -0.2% | ||
| Q4 24 | 13.9% | -6.6% | ||
| Q3 24 | 25.5% | 6.9% | ||
| Q2 24 | 21.7% | 5.3% |
净利率CORTROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 12.0% | 2.3% | ||
| Q3 25 | 9.5% | 4.0% | ||
| Q2 25 | 18.1% | -36.3% | ||
| Q1 25 | 13.1% | -0.7% | ||
| Q4 24 | 16.9% | -0.3% | ||
| Q3 24 | 25.9% | 5.1% | ||
| Q2 24 | 21.7% | 3.8% |
每股收益（稀释后）CORTROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.20 | $0.20 | ||
| Q3 25 | $0.16 | $0.48 | ||
| Q2 25 | $0.29 | $-4.00 | ||
| Q1 25 | $0.17 | $-0.08 | ||
| Q4 24 | $0.25 | $-0.04 | ||
| Q3 24 | $0.41 | $0.58 | ||
| Q2 24 | $0.32 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $1.2B |
| 总资产 | $836.7M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $372.2M | $197.0M | ||
| Q3 25 | $421.7M | $167.8M | ||
| Q2 25 | $342.2M | $157.2M | ||
| Q1 25 | $322.8M | $175.6M | ||
| Q4 24 | $383.3M | $159.8M | ||
| Q3 24 | $380.3M | $146.4M | ||
| Q2 24 | $473.2M | $119.9M |
股东权益CORTROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $647.8M | $1.2B | ||
| Q3 25 | $631.9M | $1.2B | ||
| Q2 25 | $635.8M | $1.2B | ||
| Q1 25 | $683.3M | $1.3B | ||
| Q4 24 | $679.6M | $1.3B | ||
| Q3 24 | $638.8M | $1.3B | ||
| Q2 24 | $596.2M | $1.3B |
总资产CORTROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $836.7M | $1.4B | ||
| Q3 25 | $823.6M | $1.4B | ||
| Q2 25 | $801.7M | $1.5B | ||
| Q1 25 | $846.5M | $1.5B | ||
| Q4 24 | $840.6M | $1.5B | ||
| Q3 24 | $784.3M | $1.5B | ||
| Q2 24 | $714.6M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $1.1M |
| 自由现金流率自由现金流/营收 | 19.0% | 0.5% |
| 资本支出强度资本支出/营收 | 0.0% | 2.3% |
| 现金转化率经营现金流/净利润 | 1.58× | 1.29× |
| 过去12个月自由现金流最近4个季度 | — | $70.1M |
8季度趋势，按日历期对齐
经营现金流CORTROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $38.4M | $46.9M | ||
| Q3 25 | $54.5M | $28.9M | ||
| Q2 25 | $43.9M | $13.7M | ||
| Q1 25 | $5.1M | $11.7M | ||
| Q4 24 | $59.3M | $33.7M | ||
| Q3 24 | $73.8M | $42.4M | ||
| Q2 24 | $41.2M | $22.9M |
自由现金流CORTROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $38.4M | $42.2M | ||
| Q3 25 | — | $21.2M | ||
| Q2 25 | $43.9M | $5.6M | ||
| Q1 25 | $5.0M | $2.1M | ||
| Q4 24 | $59.2M | $18.3M | ||
| Q3 24 | $72.2M | $25.2M | ||
| Q2 24 | $40.8M | $8.8M |
自由现金流率CORTROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 19.0% | 20.9% | ||
| Q3 25 | — | 9.8% | ||
| Q2 25 | 22.6% | 2.8% | ||
| Q1 25 | 3.2% | 1.1% | ||
| Q4 24 | 32.5% | 9.5% | ||
| Q3 24 | 39.5% | 12.0% | ||
| Q2 24 | 24.9% | 4.1% |
资本支出强度CORTROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 3.6% | ||
| Q2 25 | 0.0% | 4.0% | ||
| Q1 25 | 0.1% | 5.0% | ||
| Q4 24 | 0.1% | 8.0% | ||
| Q3 24 | 0.9% | 8.2% | ||
| Q2 24 | 0.3% | 6.6% |
现金转化率CORTROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 1.58× | 10.20× | ||
| Q3 25 | 2.77× | 3.36× | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | 3.96× | ||
| Q2 24 | 1.16× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
